Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Harland

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
British Journal of Hospital Medicine (London, England : 2005)|July 11, 2006
The genetics of melanomaJulia Newton Bishop, Mark Harland, D Tim Bishop
Acta Dermato-Venereologica|April 30, 2020
Melanoma GenomicsJulia Newton-Bishop, D Timothy Bishop, Mark Harland
Pharmaceuticals (Basel, Switzerland)|September 28, 2023
Revisiting p38 Mitogen-Activated Protein Kinases (MAPK) in Inflammatory Arthritis: A Narrative of the Emergence of MAPK-Activated Protein Kinase Inhibitors (MK2i)Payal Ganguly, Tom Macleod, Chi Wong, et al.
The Lancet. Oncology|January 2, 2007
Management of familial melanomaJulia Newton Bishop, Mark Harland, Juliette Randerson-Moor, et al.
Genes, Chromosomes & Cancer|May 10, 2005
A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutationAnders Molven, Magne B Grimstvedt, Solrun J Steine, et al.
International Journal of Molecular Sciences|March 28, 2026
Genotype-Encoded UV Sensitivity in iPSC-Derived Human Melanocytes Reveals MX2 as a Physiological Amplifier of p53/p38-Mediated DNA Damage SignalingEric Ramirez-Salazar, Ana Slipicevic, Marina Juraleviciute, et al.
Melanoma Research|September 17, 2019
A novel germline variant in the DOT1L gene co-segregating in a Dutch family with a history of melanomaCatarina Salgado, Eliza Mari Kwesi-Maliepaard, Aart G Jochemsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2012
Clinicopathologic features of V600E and V600K melanoma--letterRosalyn Jewell, Philip Chambers, Mark Harland, et al.
Oncotarget|October 27, 2015
The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 bindingAlessandra Bisio, Elisa Latorre, Virginia Andreotti, et al.
Genes & Nutrition|May 14, 2026
The relationship between elongation of very long-chain fatty acids (ELOVL) 2 polymorphism rs953413 and blood n-3 HUFA levels: a secondary analysis of EPA treatment in the seAFOod polyp prevention trialGe Sun, John R Davies, Tracey Mell, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
British Journal of Hospital Medicine (London, England : 2005)|July 11, 2006
The genetics of melanomaJulia Newton Bishop, Mark Harland, D Tim Bishop
Acta Dermato-Venereologica|April 30, 2020
Melanoma GenomicsJulia Newton-Bishop, D Timothy Bishop, Mark Harland
Pharmaceuticals (Basel, Switzerland)|September 28, 2023
Revisiting p38 Mitogen-Activated Protein Kinases (MAPK) in Inflammatory Arthritis: A Narrative of the Emergence of MAPK-Activated Protein Kinase Inhibitors (MK2i)Payal Ganguly, Tom Macleod, Chi Wong, et al.
The Lancet. Oncology|January 2, 2007
Management of familial melanomaJulia Newton Bishop, Mark Harland, Juliette Randerson-Moor, et al.
Genes, Chromosomes & Cancer|May 10, 2005
A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutationAnders Molven, Magne B Grimstvedt, Solrun J Steine, et al.
International Journal of Molecular Sciences|March 28, 2026
Genotype-Encoded UV Sensitivity in iPSC-Derived Human Melanocytes Reveals MX2 as a Physiological Amplifier of p53/p38-Mediated DNA Damage SignalingEric Ramirez-Salazar, Ana Slipicevic, Marina Juraleviciute, et al.
Melanoma Research|September 17, 2019
A novel germline variant in the DOT1L gene co-segregating in a Dutch family with a history of melanomaCatarina Salgado, Eliza Mari Kwesi-Maliepaard, Aart G Jochemsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2012
Clinicopathologic features of V600E and V600K melanoma--letterRosalyn Jewell, Philip Chambers, Mark Harland, et al.
Oncotarget|October 27, 2015
The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 bindingAlessandra Bisio, Elisa Latorre, Virginia Andreotti, et al.
Genes & Nutrition|May 14, 2026
The relationship between elongation of very long-chain fatty acids (ELOVL) 2 polymorphism rs953413 and blood n-3 HUFA levels: a secondary analysis of EPA treatment in the seAFOod polyp prevention trialGe Sun, John R Davies, Tracey Mell, et al.
Pageof 8